Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cottam

Showing results (491-500 of 563) with videos related to

Pageof 57
Sort By:
Plos One|June 10, 2016
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation TherapyKristina H Young, Jason R Baird, Talicia Savage, et al.
European Journal of Dermatology : EJD|November 15, 2013
Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effectsBrian Crain, Shiyin Yao, Vina Keophilaone, et al.
Archives of Public Health = Archives Belges De Sante Publique|July 17, 2020
An interpersonal nutrition campaign and maternal knowledge and childhood feeding practices: a case study from mothers in rural IndonesiaCecily Starkweather, Ayla Guarino, Natalie Bennion, et al.
Biomed Research International|November 9, 2018
Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer ImmunotherapyFumi Sato-Kaneko, Xiaodong Wang, Shiyin Yao, et al.
Cellular Immunology|July 12, 2001
Hypoestoxide, a novel anti-inflammatory natural diterpene, inhibits the activity of IkappaB kinaseE A Ojo-Amaize, P Kapahi, V N Kakkanaiah, et al.
Pilot and Feasibility Studies|July 18, 2024
The Relational Approach to Treating Self-Harm (RELATE): study protocol for a feasibility randomised controlled trial study of cognitive analytic therapy for adults who self-harm versus treatment at usualPeter James Taylor, Isabel Adeyemi, Katie Marlow, et al.
Vaccine|October 9, 2025
Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligandTomoko Hayashi, Shiyin Yao, Fumi Sato-Kaneko, et al.
Frontiers in Pharmacology|April 28, 2022
A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory ActivityNikunj M Shukla, Fumi Sato-Kaneko, Shiyin Yao, et al.
Npj Metabolic Health and Disease|March 17, 2025
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progressionSandesh J Marathe, Emily W Grey, Margaret S Bohm, et al.
Psychiatry Research|November 29, 2025
The relational approach to treating self-harm (RELATE): A feasibility randomised controlled trial of cognitive analytic therapy for adults who self-harm versus treatment at usualPeter James Taylor, Isabel Adeyemi, Katie Marlow, et al.
Pageof 57

Showing results (491-500 of 563) with videos related to

Sort By:
Pageof 57
Plos One|June 10, 2016
Optimizing Timing of Immunotherapy Improves Control of Tumors by Hypofractionated Radiation TherapyKristina H Young, Jason R Baird, Talicia Savage, et al.
European Journal of Dermatology : EJD|November 15, 2013
Inhibition of keratinocyte proliferation by phospholipid-conjugates of a TLR7 ligand in a Myc-induced hyperplastic actinic keratosis model in the absence of systemic side effectsBrian Crain, Shiyin Yao, Vina Keophilaone, et al.
Archives of Public Health = Archives Belges De Sante Publique|July 17, 2020
An interpersonal nutrition campaign and maternal knowledge and childhood feeding practices: a case study from mothers in rural IndonesiaCecily Starkweather, Ayla Guarino, Natalie Bennion, et al.
Biomed Research International|November 9, 2018
Discovery of a Novel Microtubule Targeting Agent as an Adjuvant for Cancer ImmunotherapyFumi Sato-Kaneko, Xiaodong Wang, Shiyin Yao, et al.
Cellular Immunology|July 12, 2001
Hypoestoxide, a novel anti-inflammatory natural diterpene, inhibits the activity of IkappaB kinaseE A Ojo-Amaize, P Kapahi, V N Kakkanaiah, et al.
Pilot and Feasibility Studies|July 18, 2024
The Relational Approach to Treating Self-Harm (RELATE): study protocol for a feasibility randomised controlled trial study of cognitive analytic therapy for adults who self-harm versus treatment at usualPeter James Taylor, Isabel Adeyemi, Katie Marlow, et al.
Vaccine|October 9, 2025
Enhancing vaccine immunogenicity through heterologous prime-boost regimen with multiple nasal boosting with liposomal TLR7 ligandTomoko Hayashi, Shiyin Yao, Fumi Sato-Kaneko, et al.
Frontiers in Pharmacology|April 28, 2022
A Triple High Throughput Screening for Extracellular Vesicle Inducing Agents With Immunostimulatory ActivityNikunj M Shukla, Fumi Sato-Kaneko, Shiyin Yao, et al.
Npj Metabolic Health and Disease|March 17, 2025
Incretin triple agonist retatrutide (LY3437943) alleviates obesity-associated cancer progressionSandesh J Marathe, Emily W Grey, Margaret S Bohm, et al.
Psychiatry Research|November 29, 2025
The relational approach to treating self-harm (RELATE): A feasibility randomised controlled trial of cognitive analytic therapy for adults who self-harm versus treatment at usualPeter James Taylor, Isabel Adeyemi, Katie Marlow, et al.
Pageof 57